In this study, we report that OPN contributes to acquired EGFR-TKI resistance by up-regulating expression of integrins αv and β3, which activates the downstream FAK/AKT and ERK signalling pathways to promote cell proliferation in NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.